Hand Sanitizer Recalled for Manufacturing Practice Deviations
Fisher Scientific voluntarily recalls HSANI500ML hand sanitizer (75% isopropyl alcohol) due to manufacturing practice deviations. The product was made under expired temporary FDA approval.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II voluntary precautionary recall for manufacturing practice deviations. The source does not report illnesses or injuries, and the hazard is regulatory non-compliance rather than a direct product safety defect.
Plain-English summary
Fisher Scientific Co., LLC is voluntarily recalling HSANI500ML hand sanitizer containing 75% isopropyl alcohol. The recall affects 1,077 individual 500 mL bottles and 52 cases (6 bottles per case), distributed nationwide.
The recall is due to manufacturing practice deviations. The affected products were produced under temporary FDA approval that was set to expire on March 31, 2022. Per FDA guidance, products produced under this temporary approval should not be placed on the market after that date.
Consumers with affected products should discontinue use. Contact Fisher Scientific Co., LLC for instructions on return or replacement.
The recalled product
- Product
- Hand Sanitizer, HSANI500ML, (Isopropyl Alcohol), 75% v/v, packaged in a) 500 mL bottle and b) 6 x 500 mL bottles per case, Thermo Fisher Scientific: Janssen Pharmaceuticalaan 3a, 2440 Geel - Belgium, 1 Reagent Lane, Fair Lawn, NJ 07410.
- Manufacturer
- Fisher Scientific Co., LLC
- Category
- Drug — Hand Sanitizer
- Hazard
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot Numbers: 202160
- 202162
- 202324
- 202368
- 202369
- 202593
- 202594
- 202835
- 202862
- 202863
- 202865
- 202836
- 202864
- 203061
- 203098
- 203099
- 203100
- 203101
- 203102
- 203236
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27